 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
JR6-L3355 |
 |
[1,1'-Binaphthalene]-2,2'-diol, 6,6'-diiodo-, (1S)- (9CI) |
96%
|
|
Delete |
JR6-L6670 |
 |
[1,1'-Binaphthalene]-2,2'-dithiol |
96%
|
|
Delete |
AS-0461 |
 |
1-Butyl-3-methylimidazolium bromide |
98%
|
|
Delete |
JR6-L2839 |
 |
1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-5-oxo-, ethyl ester |
96%
|
|
Delete |
AS-7721 |
 |
2,4,6-TRIMETHYLPHENYLHYDRAZINE HYDROCHLORIDE |
98%
|
|
Delete |
AS-4847 |
 |
2-Chloro-4,6-dimethoxy-1,3,5-triazine |
98%
|
|
Delete |
AS-5398 |
 |
3-CHLOROTHIOPHENOL |
98%
|
|
Delete |
JR6-L6741 |
 |
3H-Pyrazol-3-one, 2-(4-bromophenyl)-1,2-dihydro-5-(trifluoromethyl)- |
96%
|
$680/1g, $2980/5g |
Delete |
AS-6291 |
 |
4-Bromo-2-furaldehyde |
98%
|
|
Delete |
AS-3640 |
 |
4-Chloro-7-azaindole |
98%
|
|
Delete |
AS-6289 |
 |
4-Nitro-D-phenylalanine hydrate |
98%
|
|
Delete |
AS-8261 |
 |
5-Methyl-2-nitrophenol |
98%
|
|
Delete |
JR8-N0954 |
 |
Ajugol |
98%
|
|
Delete |
JR6-L4098 |
 |
Benzenebutanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-, (ßR)- |
96%
|
|
Delete |
JR6-L4442 |
 |
Benzonitrile, 2-chloro-4-[(3R)-3-hydroxy-1-pyrrolidinyl]- |
96%
|
|
Delete |
JR8-N0146 |
 |
Coumarin |
98%
|
$98/100mg, $398/500mg, $518/1g, 5g |
Delete |
AS-3308 |
 |
Ethyl cyclopropanecarboxylate |
98%
|
|
Delete |
JR8-N1089 |
 |
Isoeugenol |
98%
|
$200/20mg |
Delete |
JR8-N0361 |
 |
Ligustilide |
98%
|
$600/20mg |
Delete |
AS-5400 |
 |
Methyl 3-cyanobenzoate |
98%
|
|
Delete |
JR8-N0514 |
 |
Nitidine chloride |
98%
|
$168/20mg, 100mg, 500mg, 1g, 5g |
Delete |
JR8-N0428 |
 |
Polyphyllin VI |
98%
|
$900/20mg |
Delete |
JR8-N0646 |
 |
Prunetin |
98%
|
|
Delete |
JR6-L4683 |
 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-6-(1-methylethoxy)-4-oxo-, 1,1-dimethylethyl ester |
96%
|
|
Delete |
JR6-L4790 |
 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 8-[(cyclopentylmethyl)amino]-3,4-dihydro-6-methyl-4-oxo-, 1,1-dimethylethyl ester |
96%
|
|
Delete |
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |